Riggs Asset Managment Co. Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$3,419
-1.5%
2210.0%0.00%0.0%
Q2 2023$3,472
-4.7%
2210.0%0.00%0.0%
Q1 2023$3,643
+5.7%
2210.0%0.00%0.0%
Q4 2022$3,448
+14.9%
2210.0%0.00%0.0%
Q3 2022$3,0000.0%2210.0%0.00%0.0%
Q2 2022$3,0000.0%2210.0%0.00%0.0%
Q1 2022$3,0000.0%2210.0%0.00%0.0%
Q4 2021$3,000
-25.0%
2210.0%0.00%0.0%
Q3 2021$4,0000.0%2210.0%0.00%0.0%
Q2 2021$4,0000.0%2210.0%0.00%0.0%
Q1 2021$4,0000.0%2210.0%0.00%0.0%
Q4 2020$4,000
+33.3%
2210.0%0.00%0.0%
Q3 2020$3,0000.0%2210.0%0.00%0.0%
Q2 2020$3,0000.0%2210.0%0.00%
-50.0%
Q1 2020$3,000
-25.0%
2210.0%0.00%0.0%
Q4 2019$4,000
+33.3%
2210.0%0.00%0.0%
Q3 2019$3,000
-25.0%
2210.0%0.00%0.0%
Q2 2019$4,0000.0%2210.0%0.00%
-33.3%
Q1 2019$4,0002210.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders